Our Pricing

Mounjaro Sulfur Burps Timeline: What to Expect Weekly

Published on: June 03, 2026

Understanding the mounjaro sulfur burps timeline UK helps you prepare for one of the most commonly reported digestive side effects of tirzepatide treatment. Sulfur burps — characterised by a distinctive rotten egg smell caused by hydrogen sulfide gas — typically emerge during dose escalation phases and follow a predictable pattern in most patients. Our UK clinical team has supported thousands of Mounjaro patients through this temporary side effect, and this week-by-week guide draws on both published trial data and real-world experience to help you know what to expect.

What Causes Sulfur Burps on Mounjaro?

Mounjaro (tirzepatide) works by activating GIP and GLP-1 receptors, which slow gastric emptying — the rate at which food leaves your stomach [1]. This delayed emptying is part of how tirzepatide reduces appetite and supports weight loss, but it also means food sits in the digestive tract longer than usual.

When protein-rich foods remain in the stomach for extended periods, gut bacteria break down sulfur-containing amino acids (like methionine and cysteine) into hydrogen sulfide gas [2]. This gas produces the characteristic rotten egg smell when released as a burp. The slower your stomach empties, the more opportunity bacteria have to produce hydrogen sulfide.

Clinical trials of tirzepatide reported gastrointestinal side effects in approximately 20-30% of participants, with symptoms typically mild to moderate in severity [1]. Sulfur burps weren't always separately categorised in trial data, but they fall within the broader category of eructation (belching) and dyspepsia reported in SURPASS studies.

Week-by-Week Mounjaro Sulfur Burps Timeline

The first dose escalation occurs at week 5, when most patients move to 5mg weekly. This doubling of the dose often triggers the first noticeable sulfur burps for many patients. Expect symptoms to emerge 24-72 hours after your injection, coinciding with peak tirzepatide levels in your bloodstream. The burps may be accompanied by mild bloating, slower digestion, and occasional nausea — all signs that gastric emptying has slowed further.

By weeks 8-12, your body typically begins adapting to the 5mg dose. Sulfur burps that appeared in weeks 5-7 often diminish in frequency and intensity as your gut microbiome adjusts and you learn which foods trigger symptoms. However, if you escalate to 7.5mg at week 9 (as many treatment protocols recommend), you may experience a temporary resurgence of symptoms for 1-2 weeks before they settle again.

Weeks 1-4: Starting Dose (2.5mg)

Most patients begin Mounjaro at 2.5mg weekly. During this initial month, sulfur burps are relatively uncommon because the dose is deliberately kept low to allow your digestive system to adapt. If burps do occur, they're typically mild and infrequent — perhaps once or twice weekly rather than daily. Your body is beginning to adjust to slower gastric emptying, but the effect isn't yet pronounced enough to cause significant hydrogen sulfide production in most people.

Higher Dose Phases and Long-Term Patterns

As you progress to 10mg, 12.5mg, or 15mg doses — typically at four-week intervals — each escalation may bring a brief return of sulfur burps lasting 5-10 days. The pattern is usually consistent: symptoms peak 2-3 days post-injection, gradually improve over the following week, then resurge mildly with the next dose increase.

Clinical experience suggests that sulfur burps become less problematic over time, even at higher doses. By month 4-6 of treatment, most patients report either complete resolution or only occasional mild symptoms, particularly after high-protein meals [2]. Your gut bacteria composition changes in response to slower transit times, and you develop better awareness of dietary triggers.

A small percentage of patients (approximately 5-10% based on our dispensing experience) continue to experience persistent sulfur burps beyond six months. If symptoms remain troublesome despite dietary modifications, your UK prescriber may consider dose adjustment or alternative GLP-1 treatments with different side effect profiles.

Evidence-Based Management Strategies for Mounjaro Sulfur Burps

Staying well-hydrated supports digestive function and may help move food through your system more efficiently despite slowed gastric emptying. Aim for at least 2 litres of water daily, spread throughout the day rather than consumed in large amounts with meals. Peppermint tea and ginger tea both have traditional use for digestive comfort and may provide symptomatic relief.

Probiotics containing Lactobacillus and Bifidobacterium strains may help rebalance gut bacteria composition, though evidence specific to GLP-1-induced sulfur burps is limited [3]. If you choose to try probiotics, select a product with at least 10 billion CFU and give it 4-6 weeks to show effect. Always inform your prescriber about any supplements you're taking.

Dietary Modifications That Help

Reducing sulfur-rich foods during the first 3-4 days after each injection can significantly decrease hydrogen sulfide production. High-sulfur foods include red meat, eggs, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions, and dairy products. You don't need to eliminate these permanently — just moderate intake during the peak symptom window.

Smaller, more frequent meals reduce the volume of food sitting in your stomach at any time, giving bacteria less material to ferment. Eating slowly and chewing thoroughly also aids digestion. Many patients find that switching from three large meals to five smaller ones virtually eliminates sulfur burps, even without changing food choices.

When to Contact Your UK Prescriber About Sulfur Burps

While sulfur burps are generally harmless and temporary, certain symptoms warrant clinical review. Contact your prescriber if burps are accompanied by severe abdominal pain, persistent vomiting (more than 24 hours), inability to keep down fluids, or signs of dehydration such as dark urine or dizziness when standing.

Similarly, if sulfur burps persist beyond 12 weeks at a stable dose, or if they're severe enough to affect your nutrition or quality of life, your prescriber may adjust your treatment plan. Options include temporarily reducing the dose, slowing the escalation schedule, or considering alternative weight loss medications with different mechanisms of action.

It's worth noting that sulfur burps don't indicate treatment failure or poor response to Mounjaro. In the SURPASS-1 trial, patients achieved an average 15-22.5% body weight reduction depending on dose, regardless of whether they experienced gastrointestinal side effects [1]. Most patients who persist through the initial adjustment period go on to achieve significant weight loss results.

Comparing Mounjaro Sulfur Burps to Other GLP-1 Treatments

At Cured Pharmacy, all GLP-1 weight loss treatments require a clinical assessment by our UK-registered prescribers before dispensing. Our online consultation takes under 3 minutes and allows our clinical team to review your medical history, current medications, and treatment goals to recommend the most appropriate option. Prices are transparent and displayed upfront: Mounjaro from £124.99, subject to prescriber approval and dose prescribed.

How Wegovy and Saxenda Compare

Wegovy (semaglutide) and Saxenda (liraglutide) both slow gastric emptying through GLP-1 receptor activation, so sulfur burps can occur with these medications too. However, tirzepatide's dual GIP/GLP-1 mechanism may produce more pronounced gastric delay, potentially explaining why some patients report more frequent burps on Mounjaro than previous GLP-1 treatments [4].

Saxenda requires daily injections, which means gastric emptying effects are more constant rather than peaking weekly. Some patients find this steadier state produces fewer burps, while others prefer the weekly injection schedule of Mounjaro despite temporary digestive symptoms. Your UK prescriber can help determine which treatment profile suits your individual response and lifestyle.

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Suarez, F., Furne, J., Springfield, J., & Levitt, M. (1997). Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut, 43(1), 100-104. https://doi.org/10.1136/gut.43.1.100 [accessed 13 August 2026]
3. Dimidi, E., Christodoulides, S., Scott, S. M., & Whelan, K. (2017). Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Advances in Nutrition, 8(3), 484-494. https://doi.org/10.3945/an.116.014407 [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine in the UK and must be prescribed following an online consultation with our clinical team. Individual results may vary, and side effects should be discussed with your prescriber.